London, 10 August 2026

The purpose of the share buyback program is to optimise the Company’s capital structure and create additional value for shareholders.

The share buyback program is being carried out pursuant to the authorisation granted by the Annual General Meeting on 26th May 2026 and the subsequent resolution by the Board of Directors on 16th July 2026.

Under the program, Physitrack may repurchase up to 1,626,077 ordinary shares for a maximum aggregate consideration of EUR 120,000. The program commenced on 10 August 2026 and will continue until further notice, unless the maximum number of shares or maximum aggregate consideration is reached earlier.

Physitrack has appointed Pareto Securities AB to execute the share repurchases on behalf of the Company. Pareto Securities will make its trading decisions independently of, and without influence from, Physitrack.

The share repurchases will be carried out on Nasdaq Stockholm in accordance with applicable rules and regulations and within the parameters of the programme and the authorisation granted by the Annual General Meeting.

Transactions under the program will be reported to Nasdaq Stockholm on a daily basis in accordance with applicable requirements.

In addition, Physitrack will publish a press release each Monday during the program, providing details of the shares repurchased during the preceding week, including the total number of shares acquired and the volume-weighted average purchase price.